Efficacy and Safety of Immune Checkpoint Inhibitors (ICI) in Resectable Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis

被引：0
|
作者：
Xiao, T. [1 ]
Verma, S. [1 ]
Boldt, G. [1 ]
Rajeh, A. [1 ]
Breadner, D. [2 ]
Raphael, J. [3 ]
机构：
[1] Western Univ, London, ON, Canada
[2] LRCP, London, ON, Canada
[3] Western Univ, London Hlth Sci Ctr, London, ON, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
103
引用
收藏
页码：E6 / E6
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Cai, Zijing
    Zhan, Ping
    Song, Yong
    Liu, Hongbing
    Lv, Tangfeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1555 - 1566
  • [2] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
    Yang, Fang
    Wang, Yucai
    Tang, Lin
    Mansfield, Aaron Scott
    Adjei, Alex A. A.
    Leventakos, Konstantinos
    Duma, Narjust
    Wei, Jia
    Wang, Lifeng
    Liu, Baorui
    Molina, Julian R. R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Efficacy and Safety of Neoadjuvant Chemoimmunotherapy in Resectable Non-small Cell Lung Cancer (NSCLC): a systematic review and meta-analysis
    Syaj, S.
    Akhdar, M.
    Ababneh, O.
    Hamouri, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S235 - S236
  • [4] Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis
    Liu, Zijing
    Xu, Tiankai
    Chang, Pengyu
    Fu, Weijia
    Wei, Jiaying
    Xia, Chengcheng
    Wang, Qiang
    Li, Man
    Pu, Xiaoyu
    Huang, Fuxue
    Ge, Chao
    Gao, Yan
    Gong, Shouliang
    Liu, Chengjiang
    Dong, Lihua
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [5] Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis
    Wu, Jing
    Ni, Tingting
    Deng, Rong
    Li, Yan
    Zhong, Qin
    Tang, Fei
    Zhang, Qi
    Fang, Chunju
    Xue, Yingbo
    Zha, Yan
    Zhang, Yu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [6] Efficacy and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer: A systematic review and meta-analysis
    Feng, Yu
    Tao, Yunxia
    Chen, Haizhu
    Zhou, Yu
    Tang, Le
    Liu, Chenwei
    Hu, Xingsheng
    Shi, Yuankai
    THORACIC CANCER, 2023, 14 (25) : 2536 - 2547
  • [7] Efficacy and safety of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer (NSCLC): a systematic literature review
    Wagner, Gernot
    Stollenwerk, Hannah Karolina
    Klerings, Irma
    Pecherstorfer, Martin
    Gartlehner, Gerald
    Singer, Josef
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [8] The efficacy and safety of combination therapy with immune checkpoint inhibitors in non-small cell lung cancer: A meta-analysis
    Mo, Dun-Chang
    Huang, Jian-Feng
    Luo, Peng-Hui
    Huang, Shang-Xiao
    Wang, Han-Lei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 96
  • [9] Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune disease: A systematic review and meta-analysis in non-small cell lung cancer
    Aung, Wint Yan
    Lee, Chung-Shien
    Morales, Jaclyn
    Kohn, Nina
    Rahman, Husneara
    Seetharamu, Nagashree
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis
    Li, Feng
    Zhai, Suokai
    Lv, Zhuoheng
    Yuan, Ligong
    Wang, Shuaibo
    Jin, Donghui
    Yi, Hang
    Fu, Li
    Mao, Yousheng
    FRONTIERS IN ONCOLOGY, 2022, 12
12345